- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
A Cost-Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First-Line Intermediate- to Poor-Risk Advanced Renal Cell Carcinoma.
February 4, 2019
Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis.
February 1, 2019
Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
February 1, 2019
Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer.
February 1, 2019
An Integrated Score and Nomogram Combining Clinical and Immunohistochemistry Factors to Predict High ISUP Grade Clear Cell Renal Cell Carcinoma.
January 31, 2019
GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma.
January 31, 2019
Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer.
January 31, 2019
Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma.
January 30, 2019
Systematic review of modifiable risk factors for kidney cancer.
January 29, 2019
MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma.
January 29, 2019
Addressable Peptide Self-Assembly on the Cancer Cell Membrane for Sensitizing Chemotherapy of Renal Cell Carcinoma.
January 29, 2019
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database.
January 28, 2019
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer.
January 28, 2019
Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC.
January 25, 2019
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma.
January 25, 2019
The De Ritis and Neutrophil-to-Lymphocyte Ratios May Aid in the Risk Assessment of Patients with Metastatic Renal Cell Carcinoma.
January 25, 2019
Imaging Advances in the Management of Kidney Cancer.
January 24, 2019